Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.88 | 3.41 | 0.53 |
Stocks | 97.12 | 97.12 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.74 | 20.11 |
Price to Book | 2.89 | 3.33 |
Price to Sales | 2.49 | 2.62 |
Price to Cash Flow | 6.74 | 14.04 |
Dividend Yield | 1.29 | 1.80 |
5 Years Earnings Growth | 10.96 | 12.38 |
Name | Net % | Category Average |
---|---|---|
Industrials | 20.44 | 18.96 |
Financial Services | 19.61 | 14.54 |
Healthcare | 19.26 | 13.00 |
Technology | 12.68 | 19.34 |
Consumer Cyclical | 9.39 | 13.31 |
Communication Services | 8.08 | 5.35 |
Consumer Defensive | 5.46 | 6.84 |
Basic Materials | 5.09 | 6.96 |
Number of long holdings: 82
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UCB | BE0003739530 | 3.08 | 183.00 | -0.08% | |
Argen-X | NL0010832176 | 3.00 | 626.40 | -1.26% | |
Rolls-Royce Holdings | GB00B63H8491 | 2.99 | 594.00 | -0.24% | |
Deutsche Boerse | DE0005810055 | 2.86 | 231.800 | +0.96% | |
Compass | GB00BD6K4575 | 2.84 | 2,701.00 | +0.90% | |
London Stock Exchange | GB00B0SWJX34 | 2.80 | 11,800.0 | +0.86% | |
Partners Group | CH0024608827 | 2.80 | 1,350.00 | +1.12% | |
Chugai Pharmaceutical | JP3519400000 | 2.77 | 6,570.0 | -1.79% | |
Galderma | CH1335392721 | 2.77 | 109.30 | +3.04% | |
SAP | DE0007164600 | 2.74 | 256.750 | +0.29% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JOHCM Emerging Markets Opps Instl | 1.01B | 6.03 | -1.44 | 3.93 | ||
JOHCM International Select II | 379.66M | -0.15 | -7.40 | 4.11 | ||
JOHCM Global Equity Instl | 26.36M | 21.77 | -1.72 | 7.30 | ||
JOHCM Global Equity I | 2.96M | 21.74 | -1.79 | 7.20 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review